Advanced Bifurcation Systems Inc. (“ABS”), a leader in innovative solutions for bifurcation lesions in coronary angioplasty, announces that it has recently acquired all assets of Svelte Medical Systems, Inc. (“Svelte”). The acquired portfolio includes Svelte’s drug-eluting coronary stents, all intellectual property, and the related comprehensive set of US and international regulatory approvals and filings: U.S. Food and Drug Administration (“FDA”) Premarket Approval (“PMA”); Europe (CE Mark); and Japan (PMDA). This acquisition places ABS in a small group of select global companies possessing an FDA-approved drug eluting coronary stent.
Read the full article: Advanced Bifurcation Systems Inc. Acquires Svelte Medical Systems, Inc. //
Source: https://www.prnewswire.com/news-releases/advanced-bifurcation-systems-inc-acquires-svelte-medical-systems-inc-302753614.html